Focus:
Neurology
-
26 June 2019 News
NUS researchers invent new Apex test for Alzheimer’s disease
Researchers from the National University of Singapore (NUS) have invented a new blood test known as Amplified Plasmonic Exosome (Apex), capable of detecting a molecule that indicates early-stage Alzheimer's disease...
-
25 June 2019 News
C4XD collaborates with PhoreMost on Parkinson’s Disease drugs
C4X Discovery (C4XD) has partnered with UK-based biopharmaceutical company PhoreMost to accelerate the Parkinson’s Disease drug discovery pipeline.
-
20 June 2019 News
Parkinson’s disease: serotonin link discovery could lead to new screening tools
Changes to the serotonin system of the brain could act as a crucial early warning signal for Parkinson’s disease and may lead to the development of new screening tools for...
-
13 June 2019 Analysis
Carers Week 2019: how VR is helping carers empathise with their patients
A rapidly aging global population is leaving health services facing a dementia time bomb. Simulating the effects of the disease in virtual reality may enhance carers understanding of how to...
-
4 June 2019 News
Home-based brain stimulation treatment for depression launches in UK
An at-home, medical-grade brain stimulation headset has launched in the UK. The system, which is partnered with a therapy app, offers an alternative to pharmacological treatment for depression.
-
28 May 2019 News
Brain stimulation may improve sight recovery after stroke
Non-invasive brain stimulation may help speed up and improve vision recovery for cortically blind patients following a stroke or similar brain injury.
-
27 May 2019 News
AI used to detect genetic anomalies in people with autism
An artificial intelligence (AI) system has been used to detect a collective of genetic causes for autism spectrum disorder.
-
20 May 2019 Comment
FDA warns against off-label use of Stryker’s Wingspan stent
In general, intracranial stenting is still performed in rare cases, but only when other forms of medical therapy have failed.
-
17 May 2019 Comment
Approval of ADHD neurostimulation device clears path for treatments of related neurological disorders
GlobalData estimated the global market value for neurostimulation devices to be over $4.5 billion in 2017 and projects exponential growth into the future.
-
1 May 2019 Comment
Spinal cord stimulation demonstrates potential in advanced Parkinson’s disease
Axial motor symptoms are common in patients who live with Parkinson's disease for 10–15 years.